Novartis to acquire Avidity Biosciences for $12bn, boosting its RNA neuromuscular pipeline as pharma M&A heats up in the RNA ...

A Japanese registry study reveals how DanGer shock criteria predict survival in heart attack patients treated with Impella.

Discover a study showing TURP combined with TUIBN improves outcomes and reduces complications in small-volume BPH patients.

Discover how the GRACE 3.0 scoring system uses AI to personalise heart attack care and improve patient outcomes.

Older women walking 4,000+ steps, even just 1–2 days a week, had lower mortality and heart disease risk. Read more.

Gene therapy delivering protective vascular endothelial growth factor C into kidney filters reduced early diabetic kidney ...

New research uncovers widespread ghost scans in trauma ultrasound, revealing risks for quality assurance and patient safety.

Nationwide U.S. data reveal significant morbidity, mortality, and disparities associated with thrombotic events in patients ...

Nivolumab shows lasting melanoma recurrence prevention, with long-term safety, in largest-ever CheckMate 238 trial analysis.

A Finnish study reveals strong links between hyperemesis gravidarum and depression before and after pregnancy. Find out what this means for care.

Discover a study showing how early food introduction lowers the risk of IgE-mediated food allergy in children, improving long ...

Discover a study showing how community-based HCV treatment and generic DAAs achieve high cure rates among PWID in low- and ...